Nifty
:
25244.75
Sensex
:
82755.51
200.40 (0.80%)
700.40 (0.85%)
Nifty
Sensex
:
:
25244.75
82755.51
200.40 (0.80%)
700.40 (0.85%)

SMS Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :
59/99

BSE: 532815 | NSE: SMSPHARMA

NSE BSE
239.10
25-Jun-2025
  • Open
  • High
  • Low
  • Previous Close
  •  234.25
  •  239.9
  •  234.25
  •  234.20
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  41153
  •  9795560.2
  •  398
  •  176.05

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 2,119.23
  • 29.96
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 2,388.40
  • 0.17%
  • 3.24

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 66.26%
  • 1.60%
  • 26.35%
  • FII
  • DII
  • Others
  • 0.08%
  • 2.43%
  • 3.28%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 1.92
  • 11.48
  • 10.91

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.09
  • 7.85
  • 0.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 3.44
  • 8.52
  • -10.17

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 18.42
  • 25.06
  • 32.20

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 2.30
  • 2.61
  • 2.67

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.91
  • 14.68
  • 17.71

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Jun 24
Jun 23
Var%
Net Sales
248.20
245.80
0.98%
173.35
161.48
7.35%
196.75
166.64
18.07%
164.45
135.34
21.51%
Expenses
207.39
212.18
-2.26%
140.14
132.48
5.78%
165.28
138.82
19.06%
130.94
109.16
19.95%
EBITDA
40.81
33.62
21.39%
33.21
29.00
14.52%
31.47
27.82
13.12%
33.51
26.18
28.00%
EBIDTM
16.44%
13.68%
19.16%
17.96%
15.99%
16.69%
20.38%
19.35%
Other Income
1.42
1.65
-13.94%
2.13
1.49
42.95%
1.31
0.81
61.73%
1.37
0.51
168.63%
Interest
5.06
5.61
-9.80%
4.20
5.95
-29.41%
4.61
5.57
-17.24%
4.67
6.32
-26.11%
Depreciation
8.64
7.92
9.09%
8.70
8.01
8.61%
8.62
7.90
9.11%
8.38
7.69
8.97%
PBT
28.52
21.74
31.19%
22.44
16.53
35.75%
19.54
15.16
28.89%
21.83
12.68
72.16%
Tax
8.44
5.69
48.33%
5.36
4.24
26.42%
5.68
3.11
82.64%
5.46
3.87
41.09%
PAT
20.08
16.05
25.11%
17.08
12.29
38.97%
13.86
12.05
15.02%
16.37
8.81
85.81%
PATM
8.09%
6.53%
9.85%
7.61%
7.05%
7.23%
9.96%
6.51%
EPS
2.29
2.04
12.25%
2.15
1.36
58.09%
1.67
1.39
20.14%
1.95
1.10
77.27%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Net Sales
782.75
709.26
522.05
519.87
563.18
411.95
464.91
464.93
445.49
611.53
199.84
Net Sales Growth
10.36%
35.86%
0.42%
-7.69%
36.71%
-11.39%
0.00%
4.36%
-27.15%
206.01%
 
Cost Of Goods Sold
437.06
424.26
335.80
275.45
340.00
246.36
292.71
289.90
295.85
385.15
109.95
Gross Profit
345.69
285.00
186.24
244.43
223.18
165.59
172.20
175.03
149.64
226.38
89.88
GP Margin
44.16%
40.18%
35.67%
47.02%
39.63%
40.20%
37.04%
37.65%
33.59%
37.02%
44.98%
Total Expenditure
643.75
592.50
467.52
405.26
442.04
331.92
374.77
371.59
370.35
522.32
150.38
Power & Fuel Cost
-
47.12
35.97
32.58
23.31
18.99
21.75
22.57
18.23
33.81
8.95
% Of Sales
-
6.64%
6.89%
6.27%
4.14%
4.61%
4.68%
4.85%
4.09%
5.53%
4.48%
Employee Cost
-
56.78
50.08
51.02
41.17
39.35
35.59
32.80
26.92
38.11
5.81
% Of Sales
-
8.01%
9.59%
9.81%
7.31%
9.55%
7.66%
7.05%
6.04%
6.23%
2.91%
Manufacturing Exp.
-
37.87
28.08
25.80
16.28
14.89
13.29
12.14
10.35
37.94
7.31
% Of Sales
-
5.34%
5.38%
4.96%
2.89%
3.61%
2.86%
2.61%
2.32%
6.20%
3.66%
General & Admin Exp.
-
20.68
12.48
15.32
14.93
8.05
8.69
8.45
9.00
10.51
3.36
% Of Sales
-
2.92%
2.39%
2.95%
2.65%
1.95%
1.87%
1.82%
2.02%
1.72%
1.68%
Selling & Distn. Exp.
-
4.73
3.82
3.42
5.09
3.70
2.25
4.81
9.67
15.99
10.41
% Of Sales
-
0.67%
0.73%
0.66%
0.90%
0.90%
0.48%
1.03%
2.17%
2.61%
5.21%
Miscellaneous Exp.
-
1.07
1.27
1.67
1.25
0.58
0.49
0.91
0.33
0.80
10.41
% Of Sales
-
0.15%
0.24%
0.32%
0.22%
0.14%
0.11%
0.20%
0.07%
0.13%
2.30%
EBITDA
139.00
116.76
54.53
114.61
121.14
80.03
90.14
93.34
75.14
89.21
49.46
EBITDA Margin
17.76%
16.46%
10.45%
22.05%
21.51%
19.43%
19.39%
20.08%
16.87%
14.59%
24.75%
Other Income
6.23
4.46
4.91
5.20
3.45
5.11
3.40
2.39
1.45
3.61
3.03
Interest
18.54
23.60
21.97
19.16
11.19
12.32
11.92
15.48
15.82
17.11
8.23
Depreciation
34.34
31.52
32.13
32.15
22.28
22.07
19.27
19.90
19.18
19.43
4.58
PBT
92.33
66.11
5.35
68.50
91.12
50.76
62.35
60.35
41.58
56.27
39.67
Tax
24.94
16.91
1.47
0.62
30.16
18.07
20.90
19.89
5.97
14.63
14.20
Tax Rate
27.01%
25.58%
27.48%
0.91%
33.10%
35.60%
33.52%
32.96%
14.36%
26.00%
35.80%
PAT
67.39
49.20
3.88
67.88
60.96
32.69
41.45
40.45
35.61
41.64
25.47
PAT before Minority Interest
67.39
49.20
3.88
67.88
60.96
32.69
41.45
40.45
35.61
41.64
25.47
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
8.61%
6.94%
0.74%
13.06%
10.82%
7.94%
8.92%
8.70%
7.99%
6.81%
12.75%
PAT Growth
36.97%
1,168.04%
-94.28%
11.35%
86.48%
-21.13%
2.47%
13.59%
-14.48%
63.49%
 
EPS
7.60
5.55
0.44
7.65
6.87
3.69
4.67
4.56
4.01
4.69
2.87

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Shareholder's Funds
536.33
460.53
470.29
410.53
348.24
321.92
284.49
254.74
293.60
192.08
Share Capital
8.47
8.47
8.47
8.47
8.47
8.47
8.47
8.47
8.47
10.00
Total Reserves
499.29
452.06
461.82
402.06
339.77
313.45
276.02
246.28
285.14
182.07
Non-Current Liabilities
166.05
164.17
192.73
206.26
114.47
94.35
96.58
91.41
161.56
88.21
Secured Loans
120.89
119.93
148.30
146.21
67.02
61.01
70.20
73.02
109.58
65.92
Unsecured Loans
1.20
1.20
1.20
1.20
1.20
1.20
1.20
1.20
3.64
6.95
Long Term Provisions
1.16
1.40
1.57
1.84
1.73
1.52
2.18
1.35
3.43
0.00
Current Liabilities
346.72
254.97
211.48
211.43
154.21
156.05
134.29
156.00
200.43
49.03
Trade Payables
151.32
107.43
72.86
65.44
44.49
47.70
39.27
66.75
84.40
23.86
Other Current Liabilities
65.37
52.65
54.69
58.31
38.84
23.32
22.91
19.95
40.37
0.33
Short Term Borrowings
114.00
93.79
67.91
70.86
61.16
70.81
58.40
59.76
72.75
0.00
Short Term Provisions
16.03
1.10
16.02
16.82
9.72
14.22
13.71
9.54
2.90
24.84
Total Liabilities
1,049.10
879.67
874.50
828.22
616.92
572.32
515.36
502.15
655.59
329.32
Net Block
437.26
412.02
437.99
457.36
280.49
281.26
279.26
290.45
370.35
68.84
Gross Block
631.84
575.55
569.62
558.80
360.77
339.57
318.34
309.63
500.81
96.16
Accumulated Depreciation
194.58
163.53
131.63
101.44
80.29
58.31
39.08
19.18
130.46
27.32
Non Current Assets
500.20
468.96
482.45
502.88
389.13
351.22
334.04
335.80
408.04
83.85
Capital Work in Progress
30.27
33.19
11.00
6.74
42.12
18.30
8.20
7.76
12.80
15.02
Non Current Investment
10.94
10.52
21.53
27.30
25.81
26.99
28.38
29.10
20.51
0.00
Long Term Loans & Adv.
19.04
10.70
9.32
9.10
38.47
22.55
16.19
6.58
4.37
0.00
Other Non Current Assets
2.69
2.54
2.61
2.38
2.25
2.13
2.01
1.90
0.00
0.00
Current Assets
548.89
410.70
392.05
325.33
227.78
221.09
181.32
166.36
247.55
233.89
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.03
Inventories
233.70
223.50
251.10
137.79
129.20
136.40
107.48
92.52
112.68
49.57
Sundry Debtors
236.23
148.35
48.52
105.68
48.77
26.02
24.15
21.32
61.09
59.98
Cash & Bank
36.20
7.47
46.66
40.51
9.65
14.88
12.71
12.37
15.08
95.71
Other Current Assets
42.76
6.00
6.39
19.18
40.16
43.79
36.98
40.15
58.70
28.60
Short Term Loans & Adv.
35.99
25.39
39.39
22.17
19.20
17.06
14.89
11.67
23.49
26.79
Net Current Assets
202.18
155.74
180.57
113.90
73.57
65.04
47.03
10.36
47.13
184.86
Total Assets
1,049.09
879.66
874.50
828.21
616.91
572.31
515.36
502.16
655.59
329.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Cash From Operating Activity
50.12
22.45
45.06
90.45
39.71
49.76
31.81
73.47
61.22
14.33
PBT
66.11
5.35
68.50
91.12
50.76
62.35
60.35
41.58
56.27
39.67
Adjustment
53.97
52.99
49.86
27.76
28.66
26.81
31.08
31.58
28.14
18.09
Changes in Working Capital
-54.55
-31.29
-58.38
-12.38
-27.60
-26.02
-48.48
9.40
-1.17
-29.61
Cash after chg. in Working capital
65.52
27.05
59.98
106.50
51.82
63.14
42.95
82.56
83.24
28.16
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-15.40
-4.60
-14.92
-16.05
-12.10
-13.38
-11.14
-9.09
-22.02
-5.60
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-52.07
-29.76
-27.15
-151.59
-42.56
-34.67
-16.58
-38.96
-96.72
-31.70
Net Fixed Assets
-53.37
-28.12
-15.08
-162.65
-45.02
-31.33
-9.15
128.49
-346.44
Net Investments
0.00
-0.10
0.00
0.00
0.00
0.00
-8.02
-15.71
-17.94
Others
1.30
-1.54
-12.07
11.06
2.46
-3.34
0.59
-151.74
267.66
Cash from Financing Activity
30.68
-31.97
-11.75
92.02
-2.40
-12.92
-14.89
-33.19
44.34
106.55
Net Cash Inflow / Outflow
28.73
-39.27
6.16
30.88
-5.25
2.17
0.35
1.32
8.84
89.18
Opening Cash & Equivalents
7.31
46.58
40.42
9.54
14.80
12.63
12.29
11.25
2.41
6.53
Closing Cash & Equivalent
36.04
7.31
46.58
40.42
9.54
14.80
12.63
12.29
11.25
95.71

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 07
Book Value (Rs.)
59.98
54.40
55.56
48.50
41.14
38.03
33.61
30.09
34.68
18.05
ROA
5.10%
0.44%
7.97%
8.44%
5.50%
7.62%
7.95%
6.15%
8.46%
7.73%
ROE
10.16%
0.83%
15.41%
16.07%
9.76%
13.67%
15.00%
12.99%
17.57%
14.11%
ROCE
11.73%
3.79%
12.60%
17.62%
13.06%
16.57%
18.17%
12.73%
19.54%
18.91%
Fixed Asset Turnover
1.24
0.97
0.98
1.32
1.29
1.53
1.59
1.12
2.11
2.24
Receivable days
93.46
65.01
50.80
46.40
30.27
18.23
16.66
33.12
35.09
101.66
Inventory Days
111.10
156.71
128.12
80.21
107.49
88.61
73.28
82.47
47.02
84.02
Payable days
111.30
97.98
91.63
59.01
46.62
40.24
46.81
71.90
36.96
57.46
Cash Conversion Cycle
93.25
123.74
87.30
67.61
91.14
66.60
43.12
43.69
45.14
128.22
Total Debt/Equity
0.55
0.55
0.55
0.61
0.44
0.45
0.51
0.59
0.70
0.40
Interest Cover
3.80
1.24
4.57
9.14
5.12
6.23
4.90
3.63
4.29
5.82

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014
FY 2013
FY 2012
FY 2011
FY 2010

News Update:


  • SMS Pharmaceuticals completes USFDA inspection at Hyderabad facility
    22nd Mar 2025, 11:54 AM

    The inspection, conducted from March 17, 2025 to March 21, 2025, concluded with one observation in Form 483

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.